Top compounds associated with response to EFCAB11


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC 0.11 0.04
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.04
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.09 0.04
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC -0.078 0.05
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.074 0.05
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.078 0.05
mRNA paclitaxel gCSI pan-cancer AAC -0.1 0.05
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.05
mRNA prochlorperazine CTRPv2 pan-cancer AAC -0.076 0.06
mRNA Vorinostat gCSI pan-cancer AAC -0.1 0.06
Download CSV